Bupivacaine Hydrochloride recalls

Bupivacaine Hydrochloride products have been recalled 12 times, most recently on 22 Apr 2026. The recalling company is usually Hospira. The most common reason is particulate matter.

Total recalls12since 2013

Last 12 months1reported

Class I542% of total

Ongoing2latest 22 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 1 0May 0 0 0Aug 0 0

Severity split

Class I 5 42%Class II 7 58%Class III 0 0%

Why bupivacaine hydrochloride is recalled

Companies

Hospira758%
Mckesson Medical-Surgical Inc. Corporate Office217%
Huons18%
Pfizer18%
Hospira Inc. A Pfizer18%

Product types

Injectable & IV Drugs975%
Allergy Medication217%

By year

202618%
2022217%
202118%
201618%
201518%
2014325%
2013325%

Ongoing bupivacaine hydrochloride recalls

2 active

Reported	Class	Recall	Company	Reason	Where
22 Apr 2026Drug	CLASS II	Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection recalledBupivacaine Hydrochloride	Huons	Sterility	Nationwide
28 Dec 2016Drug	CLASS I	Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) recalledBupivacaine Hydrochloride	Hospira Inc. A Pfizer	Particulate Matter	Nationwide

All bupivacaine hydrochloride recalls, newest first

12 total

Reported	Class	Recall	Company	Reason	Where
22 Apr 2026Drug	CLASS II	Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection recalledBupivacaine Hydrochloride	Huons	Sterility	Nationwide
15 Jun 2022Drug	CLASS II	Bupivacaine HCl Injection, single dose vial, Preservative Free recalledBupivacaine Hydrochloride	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
15 Jun 2022Drug	CLASS II	Bupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials recalledBupivacaine Hydrochloride	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
9 Jun 2021Drug	CLASS I	0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg recalled by PFIZERBupivacaine Hydrochloride	Pfizer	Packaging Defects	Nationwide
28 Dec 2016Drug	CLASS I	Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) recalledBupivacaine Hydrochloride	Hospira Inc. A Pfizer	Particulate Matter	Nationwide
15 Jul 2015Drug	CLASS I	Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL) recalled by HospiraBupivacaine Hydrochloride	Hospira	Particulate Matter	Nationwide
24 Sep 2014Drug	CLASS II	Bupivacaine HCl Inj. recalled by HospiraBupivacaine Hydrochloride	Hospira	Particulate Matter	Nationwide
12 Mar 2014Drug	CLASS II	Bupivacaine HCl Inj recalled by HospiraBupivacaine Hydrochloride	Hospira	Particulate Matter	Nationwide
8 Jan 2014Drug	CLASS II	0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj. recalled by HospiraBupivacaine Hydrochloride	Hospira	Sterility	Nationwide
25 Dec 2013Drug	CLASS I	0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL recalled by HospiraBupivacaine Hydrochloride	Hospira	Particulate Matter	Nationwide
25 Dec 2013Drug	CLASS I	0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL recalled by HospiraBupivacaine Hydrochloride	Hospira	Particulate Matter	Nationwide
16 Oct 2013Drug	CLASS II	0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj. recalled by HospiraBupivacaine Hydrochloride	Hospira	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.